amiodarone has been researched along with Tachycardia, Supraventricular in 184 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Tachycardia, Supraventricular: A generic expression for any tachycardia that originates above the BUNDLE OF HIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of amiodarone in dogs with refractory supraventricular and ventricular arrhythmias and to document the side effects in treated dogs." | 7.78 | Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010). ( Dukes-McEwan, J; Fonfara, S; López-Alvarez, J; Pedro, B; Stephenson, H, 2012) |
| "Nurses noted that the rate of phlebitis was high when intravenous amiodarone was infused via a peripheral site." | 7.78 | Incidence and severity of phlebitis in patients receiving peripherally infused amiodarone. ( Boyce, BA; Yee, BH, 2012) |
| " During amiodarone infusion a torsade de pointes occurred, which was immediately converted to sinus rhythm by synchronized cardioversion." | 7.75 | "Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval. ( Benazzi, B; Bernardi, M; Berzigotti, A; Bracci, E; Di Micoli, A; Trevisani, F; Zambruni, A; Zappoli, P; Zoli, M, 2009) |
| "Amiodarone is a powerful antiarrhythmic drug; however, its use may be complicated by thyrotoxicosis." | 7.73 | Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis. ( Bertagna, X; Bertherat, J; Duboc, D; Guignat, L; Meune, C; Mouly, S; Thomopoulos, P; Uzan, L; Weber, S, 2006) |
| "Blood lipid levels were measured in 23 patients with amiodarone associated hypothyroidism (most of them had ischemic heart disease)." | 7.73 | [Lipid blood spectrum in patients with amiodarone associated hypothyroidism. Effect of replacement therapy with L-thyroxine]. ( Bakalov, SA; Golitsyn, SP; Kotkina, TI; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2005) |
| "We report a case of pulmonary fibrosis in an infant receiving amiodarone for treatment of intractable atrioventricular reentrant tachycardia secondary to Wolff-Parkinson-White syndrome." | 7.70 | Amiodarone induced pulmonary fibrosis in infancy. ( Bowers, PN; Fields, J; Nehgme, R; Rosenfeld, LE; Schwartz, D, 1998) |
| "Amiodarone-induced hyperthyroidism in a relatively rare complication of long-term treatment with this molecule." | 7.69 | [Value of thyroidectomy in amiodarone-induced hyperthyroidism. Apropos of 3 cases]. ( Dupuis, JM; Painvin, I; Rohmer, V; Ronceray, J; Tadéi, A; Victor, J, 1996) |
| "We present a case of persistent fetal supraventricular tachycardia where transplacental and direct fetal treatment with amiodarone caused an iatrogenic hypothyroidism." | 7.69 | Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia. ( Bougatef, A; De Catte, L; De Schepper, J; De Wolf, D; Foulon, W; Smitz, J, 1994) |
| "The safety and efficacy of short intravenous therapy with amiodarone were evaluated in 44 patients (24 males, 20 females), aged 21-84 years, with supraventricular tachyarrhythmias newly arisen in less than 24 hours." | 7.68 | Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias. ( Burzio, P; Latini, R; Marchisio, U; Veglio, F; Vietti-Ramus, G, 1992) |
| "In a patient chronically treated with amiodarone, subclinical iodine-induced hypothyroidism occurred as a result of excess iodine released from the amiodarone molecule." | 7.68 | Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone. ( Bianconi, L; Gardini, E; Minelli, R; Roti, E; Salvi, M, 1992) |
| " Since amiodarone combined with propylthiouracil induced a greater fall in serum thyroid hormone concentrations than propylthiouracil alone, we treated 2 hyperthyroid patients with supraventricular arrhythmias by radioiodine (day 0) followed after 24 h by amiodarone and propylthiouracil." | 7.68 | Treatment of supraventricular tachyarrhythmias associated with hyperthyroidism by radioiodine, amiodarone and propylthiouracil. ( Lipski, A; Mavroudakis, N; Unger, J; van Coevorden, A, 1991) |
| "The effect of intravenous (IV) amiodarone (300 mg) on heart rate was investigated in 22 patients with acute myocardial infarction (18) or ischemia (4) and sinus tachycardia." | 7.67 | The effect of intravenous amiodarone on heart rate in patients with acute myocardial infarction or ischemia and sinus tachycardia. ( Agmon, J; Klainman, E; Kusniec, J; Sclarovsky, S; Strasberg, B, 1988) |
| "A double-blind, randomized, multicenter, dose-response study of the safety and efficacy of IV amiodarone was conducted in 61 children (30 days to 14." | 6.71 | Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. ( Acevedo, V; Brown, S; Burriss, SW; Cargo, P; Etheridge, SP; Graepel, J; Koskelo, EK; Marantz, P; Perry, JC; Saul, JP; Scott, WA; Triedman, JK; Wang, R, 2005) |
| "Amiodarone was continued for 45 days; there was no recurrence of atrial flutter." | 6.44 | Successful treatment of atrial flutter with amiodarone in a premature neonate. Case report and literature review. ( Bauersfeld, U; Knirsch, W; Kretschmar, O; Uhlemann, F; Vogel, M, 2007) |
| "Treatment with amiodarone was continued; however, therapy with L-thyroxin was initiated, followed by a complete regression of the goiter." | 5.28 | Goiter and hypothyroidism during re-treatment with amiodarone in a patient who previously experienced amiodarone-induced thyrotoxicosis. ( Ish-Shalom, S; Kaplan, J, 1991) |
| "Amiodarone is widely used in intensive care units for the treatment of a variety of arrhythmias." | 4.80 | Intravenous amiodarone in intensive care. Time for a reappraisal? ( Binning, A; Hughes, M, 2000) |
| "Amiodarone, an anti-ischaemic and anti-arrhythmic drug, has been the object of numerous studies and seems to be highly effective in the treatment of severe ventricular arrhythmias on dilated cardiomyopathies, as well as of hypertrophic or ischaemic heart diseases." | 4.78 | [Does amiodarone have a benefit effect on mortality?]. ( Kahn, JC; Pathé, M, 1991) |
| "To evaluate the efficacy of amiodarone in dogs with refractory supraventricular and ventricular arrhythmias and to document the side effects in treated dogs." | 3.78 | Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010). ( Dukes-McEwan, J; Fonfara, S; López-Alvarez, J; Pedro, B; Stephenson, H, 2012) |
| "Nurses noted that the rate of phlebitis was high when intravenous amiodarone was infused via a peripheral site." | 3.78 | Incidence and severity of phlebitis in patients receiving peripherally infused amiodarone. ( Boyce, BA; Yee, BH, 2012) |
| "Propranolol was given to 16 patients, with two successes and one partial success." | 3.76 | Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study. ( Cifarelli, A; Garcia, JM; Garson, A; Herre, J; Vetter, VL; Villain, E, 1990) |
| " During amiodarone infusion a torsade de pointes occurred, which was immediately converted to sinus rhythm by synchronized cardioversion." | 3.75 | "Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval. ( Benazzi, B; Bernardi, M; Berzigotti, A; Bracci, E; Di Micoli, A; Trevisani, F; Zambruni, A; Zappoli, P; Zoli, M, 2009) |
| "Blood lipid levels were measured in 23 patients with amiodarone associated hypothyroidism (most of them had ischemic heart disease)." | 3.73 | [Lipid blood spectrum in patients with amiodarone associated hypothyroidism. Effect of replacement therapy with L-thyroxine]. ( Bakalov, SA; Golitsyn, SP; Kotkina, TI; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2005) |
| "Amiodarone is a powerful antiarrhythmic drug; however, its use may be complicated by thyrotoxicosis." | 3.73 | Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis. ( Bertagna, X; Bertherat, J; Duboc, D; Guignat, L; Meune, C; Mouly, S; Thomopoulos, P; Uzan, L; Weber, S, 2006) |
| "We report a case of pulmonary fibrosis in an infant receiving amiodarone for treatment of intractable atrioventricular reentrant tachycardia secondary to Wolff-Parkinson-White syndrome." | 3.70 | Amiodarone induced pulmonary fibrosis in infancy. ( Bowers, PN; Fields, J; Nehgme, R; Rosenfeld, LE; Schwartz, D, 1998) |
| "To investigate any relationship between the pathological features of amiodarone-induced pulmonary toxicity (APT) and clinical use of amiodarone in patients dying from acute respiratory distress syndrome (ARDS)." | 3.70 | Acute amiodarone-induced lung toxicity. ( Donaldson, L; Grant, IS; Naysmith, MR; Thomas, JS, 1998) |
| " After failure of initial transplacental treatment, the injection of amiodarone into the umbilical vein combined with evacuation of ascites achieved conversion to sinus rhythm and restored cardiac function thus allowing pregnancy to go to term." | 3.70 | Successful treatment of refractory supraventricular tachycardia by repeat intravascular injection of amiodarone in a fetus with hydrops. ( Guyon, F; Horovitz, J; Jimenez, M; Mangione, R; Saura, R; Vergnaud, A, 1999) |
| "We present a case of persistent fetal supraventricular tachycardia where transplacental and direct fetal treatment with amiodarone caused an iatrogenic hypothyroidism." | 3.69 | Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia. ( Bougatef, A; De Catte, L; De Schepper, J; De Wolf, D; Foulon, W; Smitz, J, 1994) |
| "Amiodarone-induced hyperthyroidism in a relatively rare complication of long-term treatment with this molecule." | 3.69 | [Value of thyroidectomy in amiodarone-induced hyperthyroidism. Apropos of 3 cases]. ( Dupuis, JM; Painvin, I; Rohmer, V; Ronceray, J; Tadéi, A; Victor, J, 1996) |
| " Since amiodarone combined with propylthiouracil induced a greater fall in serum thyroid hormone concentrations than propylthiouracil alone, we treated 2 hyperthyroid patients with supraventricular arrhythmias by radioiodine (day 0) followed after 24 h by amiodarone and propylthiouracil." | 3.68 | Treatment of supraventricular tachyarrhythmias associated with hyperthyroidism by radioiodine, amiodarone and propylthiouracil. ( Lipski, A; Mavroudakis, N; Unger, J; van Coevorden, A, 1991) |
| "The safety and efficacy of short intravenous therapy with amiodarone were evaluated in 44 patients (24 males, 20 females), aged 21-84 years, with supraventricular tachyarrhythmias newly arisen in less than 24 hours." | 3.68 | Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias. ( Burzio, P; Latini, R; Marchisio, U; Veglio, F; Vietti-Ramus, G, 1992) |
| "In a patient chronically treated with amiodarone, subclinical iodine-induced hypothyroidism occurred as a result of excess iodine released from the amiodarone molecule." | 3.68 | Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone. ( Bianconi, L; Gardini, E; Minelli, R; Roti, E; Salvi, M, 1992) |
| "The effect of intravenous (IV) amiodarone (300 mg) on heart rate was investigated in 22 patients with acute myocardial infarction (18) or ischemia (4) and sinus tachycardia." | 3.67 | The effect of intravenous amiodarone on heart rate in patients with acute myocardial infarction or ischemia and sinus tachycardia. ( Agmon, J; Klainman, E; Kusniec, J; Sclarovsky, S; Strasberg, B, 1988) |
| "The trial includes septic shock patients with new-onset arrhythmia, but without severe impairment of the left ventricular ejection fraction." | 2.90 | Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study. ( Balik, M; Brestovansky, P; Brozek, T; Duska, F; Flaksa, M; Maly, M; Matousek, V; Otahal, M; Pazout, J; Porizka, M; Rulisek, J; Sachl, R; Smid, O; Stach, Z; Stritesky, M; Svobodova, E; Waldauf, P, 2019) |
| " Amiodarone is both safe and effective in establishing sinus rhythm." | 2.71 | Is amiodarone a safe antiarrhythmic to use in supraventricular tachyarrhythmias after lung cancer surgery? ( Barbetakis, N; Vassiliadis, M, 2004) |
| "A double-blind, randomized, multicenter, dose-response study of the safety and efficacy of IV amiodarone was conducted in 61 children (30 days to 14." | 2.71 | Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. ( Acevedo, V; Brown, S; Burriss, SW; Cargo, P; Etheridge, SP; Graepel, J; Koskelo, EK; Marantz, P; Perry, JC; Saul, JP; Scott, WA; Triedman, JK; Wang, R, 2005) |
| "Amiodarone is an effective and safe therapy for tachycardia control in infancy." | 2.70 | Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants. ( Compton, SJ; Craig, JE; Etheridge, SP, 2001) |
| " Adverse effects occurred in 18 patients (58%), however none necessitated termination of amiodarone therapy." | 2.67 | Clinical efficacy and safety of intravenous Amiodarone in infants and children. ( Figa, FH; Freedom, RM; Gow, RM; Hamilton, RM, 1994) |
| "Amiodarone was administered to 53 patients with otherwise drug-refractory supraventricular tachycardias." | 2.66 | Amiodarone for refractory supraventricular tachycardias. ( Andreasen, F; Bjerregaard, P; Emmertsen, K, 1987) |
| "Amiodarone has multiple and complex electrophysiological effects that render it a very effective antiarrhythmic drug for the treatment of both, supraventricular and ventricular arrhythmias." | 2.55 | [Clinical aspects of treatment with amiodarone]. ( Haverkamp, W; Israel, C; Parwani, A, 2017) |
| "Amiodarone treatment affects thyroid status in about the half of patients." | 2.46 | [Amiodarone-induced thyroid gland dysfunctions]. ( Caglayan, E; Dietlein, M; Er, F; Erdmann, E; Gassanov, N, 2010) |
| "Amiodarone was continued for 45 days; there was no recurrence of atrial flutter." | 2.44 | Successful treatment of atrial flutter with amiodarone in a premature neonate. Case report and literature review. ( Bauersfeld, U; Knirsch, W; Kretschmar, O; Uhlemann, F; Vogel, M, 2007) |
| "We report a case of nonimmune hydrops fetalis detected at 32 weeks of gestation." | 2.43 | Amiodarone in treatment of fetal supraventricular tachycardia. A case report and review of literature. ( Kapoor, A; Manisha, M; Pradhan, M; Singh, R, 2006) |
| "Amiodarone has gained recognition as an antiarrhythmic medication after recent publication of the newly revised American Heart Association guidelines for pediatric resuscitation." | 2.42 | Amiodarone-an "old" drug with new recommendations. ( McKee, MR, 2003) |
| "Sotalol was approved for treatment of atrial fibrillation and atrial flutter (AF)." | 2.42 | Oral class III antiarrhythmics: what is new? ( Khan, MH, 2004) |
| "Patients with other supraventricular arrhythmias may be treated with adenosine, a calcium channel blocker, or a short-acting beta blocker to disrupt reentrant pathways." | 2.41 | Management of common arrhythmias: Part I. Supraventricular arrhythmias. ( Hebbar, AK; Hueston, WJ, 2002) |
| "Cardiac arrhythmias are common in the perioperative period." | 2.41 | Postoperative arrhythmias and conduction disorders. ( Sloan, SB; Weitz, HH, 2001) |
| " The most serious adverse reaction is pulmonary toxicity." | 2.40 | [Amiodarone-induced pulmonary toxicity]. ( Berg, M; Heisel, A; Schieffer, H; Stopp, M; Ukena, D, 1997) |
| "Digoxin was the initial treatment in 84." | 2.38 | [Supraventricular paroxysmal tachycardia without congenital heart disease: clinical, therapeutic aspects and course in 65 children]. ( Cabezuelo Huerta, G; Frontera Izquierdo, P, 1991) |
| "Amiodarone, which was initiated for MAT, unexpectedly ameliorated thyrotoxicosis, resulting in a euthyroid state and the patient's significantly improved condition and cardiac function." | 1.62 | Delayed diagnosis of dilated thyrotoxic cardiomyopathy with coexistent multifocal atrial tachycardia: a case report. ( Hashimoto, T; Ishibashi-Ueda, H; Monno, S; Ohta-Ogo, K; Yamamoto, H, 2021) |
| "Flecainide was used in 47 patients and amiodarone in 27 patients." | 1.51 | A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children. ( Bar-Cohen, Y; Hill, AC; Silka, MJ, 2019) |
| " Except for the dosage of noradrenaline (0." | 1.46 | Propafenone for supraventricular arrhythmias in septic shock-Comparison to amiodarone and metoprolol. ( Balik, M; Kolnikova, I; Kristof, J; Maly, M; Tavazzi, G; Waldauf, P, 2017) |
| "A recent report has described sudden death of a horse following attempted conversion of SVT with oral flecainide acetate." | 1.46 | Treatment of supraventricular tachycardia in a horse. ( Blas-Machado, U; Coleman, AE; Credille, BC; Giguère, S; Maisenbacher, HW; Rapoport, GS; Tennent-Brown, BS; Whelchel, DD, 2017) |
| "Amiodarone was injected slowly into foetal peritoneal cavity under ultrasound guidance." | 1.42 | Foetal supraventricular tachycardia with hydrops fetalis: a role for direct intraperitoneal amiodarone. ( Coleman, M; Gnanapragasam, J; Howe, D; Kang, SL; Roman, K, 2015) |
| "Amiodarone has a variable oral bioavailability." | 1.39 | [Amiodarone administered orally or intravenously - the same or different drug?]. ( Kosior, DA; Krzykwa, A; Postuła, M, 2013) |
| "She presented generalized skin rash, arthralgia on upper and lower extremities, associated with difficulty to walk." | 1.39 | An unexpected side-effect of a commonly used drug. ( Adorno, E; Fernández González, F; Fernández González, R; Miranda, S; Nieves, J; Santiago Casiano, M, 2013) |
| "Adenosine has been well studied as a mainstay treatment, but the methods of adenosine administration have not been very well delineated." | 1.38 | Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia. ( Goodman, IS; Lu, CJ, 2012) |
| "The management of ventricular tachycardia depends on clinical symptoms and is influenced by the presence of structural heart disease." | 1.37 | Electrocardiography Series. What is the cause of the regular wide QRS complex tachycardia? ( Kireyev, D; Lim, SL; Poh, KK; Teo, SG, 2011) |
| "Amiodarone was the initial therapy in 26 cases and procainamide in 14 cases." | 1.36 | Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients. ( Bar-Cohen, Y; Chang, PM; Moromisato, DY; Silka, MJ, 2010) |
| "Amiodarone was given initially to the other 4 patients in whom adenosine caused only temporary conversion to the sinus rhythm." | 1.36 | Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants. ( Aslan, Y; Celiker, A; Dilber, B; Dilber, E; Gedik, Y; Mutlu, M, 2010) |
| "Amiodarone is the treatment of choice for direct foetal therapy for SVT, and can be administered safely via the umbilical vein." | 1.35 | [Treatment of foetal supraventricular tachycardia with antiarrhythmic medication administered through the umbilical vein]. ( Blom, NA; Klumper, FJ; Oepkes, D; Rijlaarsdam, ME; Roest, AA; Vandenbussche, FP, 2008) |
| "Amiodarone is a potent antiarrhythmic drug commonly used in the treatment of supraventricular and ventricular arrhythmias." | 1.34 | Acute in vitro effects of dronedarone, an iodine-free derivative, and amiodarone, on the rabbit sinoatrial node automaticity: a comparative study. ( Celestino, D; Elizari, MV; Medei, E; Moro, S; Sicouri, S, 2007) |
| "The tachyarrhythmias were classified into atrial flutter (n = 8), supraventricular tachycardia (n = 18), arrhythmia absoluta (n = 5), parasystole (n = 1) and brady-tachyarrhythmia (n = 1)." | 1.32 | [Diagnosis and treatment of haemodynamically significant fetal tachycardia--in 33 cases]. ( Hajdú, J; Papp, Z; Pete, B, 2004) |
| " Amiodarone infusion (mean dosage 24 h: 1625+/-528 mg; 48 h: 2708+/-895 mg) restored sinus rhythm in 54% of study patients within 12 h, in 64% within 24 h, and in 75% within 48 h." | 1.32 | High-dosage continuous amiodarone therapy to treat new-onset supraventricular tachyarrhythmias in surgical intensive care patients: an observational study. ( Dünser, MW; Friesenecker, B; Hasibeder, WR; Knotzer, H; Mayr, AJ; Pajk, W; Ritsch, N; Ulmer, H; Wenzel, V, 2004) |
| "Pharmacological treatment of the supraventricular tachycardia solved the problem." | 1.32 | Inappropriate single chamber ICD discharges due to supraventricular tachycardia with high degree atrioventricular block. ( De Palma, C; Kreutzer, E; Scaglione, J; Socas, AG, 2004) |
| "Amiodarone was administered to those who developed SA with a loading dose of 5 mg/kg in 30 min and a maintenance dose of 15 mg/kg in 24 h." | 1.31 | Supraventricular arrhythmia following lung resection for non-small cell lung cancer and its treatment with amiodarone. ( Canneto, B; Ciriaco, P; Mazzone, P; Zannini, P, 2000) |
| "Hyperthyroidism is a reason for immediately suspending treatment for 90% of the cardiologists, only 5% would continue and 16% would prescribe antithyroid drugs." | 1.30 | [Amiodarone and thyroid function: clinical implications]. ( Binz, K; Burger, A; Vallotton, MB, 1998) |
| "Amiodarone was used as first line therapy or after failure of digoxin." | 1.30 | [Recommendations for the treatment of recurrent supraventricular tachycardia in infants]. ( Acar, P; Aggoun, Y; Bonnet, D; Kachaner, J; Sidi, D; Villain, E, 1998) |
| "Amiodarone hydrochloride has been in use for two decades for the control of ventricular and supraventricular arrhythmias." | 1.30 | Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety. ( Lee, KL; Tai, YT, 1997) |
| " Except for transient first-degree atrioventricular block in two patients, no adverse effects possibly related to amiodarone were observed (including proarrhythmia and incidence or aggravation of heart failure symptoms)." | 1.29 | Intravenous amiodarone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmias. ( Ceremuzyński, L; Cybulski, J; Czepiel, A; Kułakowski, P; Makowska, E; Sikora-Frac, M, 1996) |
| "In 8 patients paroxysmal atrial fibrillation (AF), in 2 patients chronic AF, in 1 patient atrial flutter, and in 3 patients sinus tachycardia triggered antitachycardia pacing functions (12 patients) or internal defibrillation (2 patients)." | 1.29 | Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators. ( Melichercik, J; Montero, M; Schmitt, C, 1994) |
| "Amiodarone has been suggested as a therapeutic alternative after failure of digoxin-verapamil combination." | 1.29 | [Successful treatment of fetal supraventricular tachycardia with a combination of digoxin and amiodarone]. ( Hajdú, J; Német, J; Szabó, I, 1996) |
| "Oral amiodarone was administered to 38 patients (25 males, 13 females) with mean age of 43." | 1.28 | Adverse effects of oral amiodarone therapy. ( Avasthey, P; Dube, S; Gupta, PR; Sinha, PR; Somani, PN, 1992) |
| "Amiodarone was clinically useful in 32 (68%) patients." | 1.28 | Use of amiodarone for short-term and adjuvant therapy in young patients. ( Benson, DW; Deal, BJ; Pongiglione, G; Strasburger, JF, 1991) |
| "Treatment with amiodarone was continued; however, therapy with L-thyroxin was initiated, followed by a complete regression of the goiter." | 1.28 | Goiter and hypothyroidism during re-treatment with amiodarone in a patient who previously experienced amiodarone-induced thyrotoxicosis. ( Ish-Shalom, S; Kaplan, J, 1991) |
| "Amiodarone was administered intravenously at a dose of 300 mg over 2 min and sotalol at a dose of 1." | 1.28 | Mechanisms of termination of supraventricular tachycardias by intravenous class III antiarrhythmic agents. A comparison of amiodarone and sotalol. ( Dehareng, A; Kulbertus, HE; Nzayinambaho, K; Rodriguez, LM; Waleffe, A, 1989) |
| " A standardized oral loading dosage was used for all patients (1,200 mg/day for 14 days; 800 mg/day for 7 days; and 400 mg/day thereafter)." | 1.28 | Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effects. ( Duff, HJ; Gillis, AM; Mitchell, LB; Wyse, DG, 1989) |
| "Flecainide was administered to other patients during spontaneous episodes of tachyarrhythmias." | 1.27 | [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination]. ( Capestro, F; Ciampani, N; Costantini, C; Fratadocchi, GB; Mazzanti, M; Molini, E; Purcaro, A, 1987) |
| "Amiodarone has been reported to be a remarkably safe and effective drug in the European and South American experience but American investigators have published conflicting data." | 1.27 | Safety and efficacy of amiodarone. The low-dose perspective. ( Friehling, TD; Kowey, PR; Marinchak, RA; Stohler, JL; Sulpizi, AM, 1988) |
| "During follow-up (10 to 28 months), ectopic atrial tachycardia resolved completely in four patients and was well controlled in four patients." | 1.27 | Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up. ( Casta, A; Donner, RM; Dunn, JM; Mehta, AV; Sacks, EJ; Sanchez, GR, 1988) |
| "The prevalence of ventricular arrhythmias was not different before and after the pacemaker implantation." | 1.27 | [Arrhythmia in patients with a DDD bicameral pacemaker]. ( Magnani, A; Occhetta, E; Perucca, A; Prando, MD; Rognoni, G; Rossi, L; Rossi, P, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (19.57) | 18.7374 |
| 1990's | 60 (32.61) | 18.2507 |
| 2000's | 50 (27.17) | 29.6817 |
| 2010's | 31 (16.85) | 24.3611 |
| 2020's | 7 (3.80) | 2.80 |
| Authors | Studies |
|---|---|
| Lei, LY | 1 |
| Chew, DS | 1 |
| Lee, W | 1 |
| Meng, Z | 1 |
| Ilhan, E | 1 |
| Furlan, R | 1 |
| Sheldon, RS | 2 |
| Pollak, PT | 1 |
| Raj, SR | 1 |
| Ciriello, GD | 1 |
| Colonna, D | 1 |
| Papaccioli, G | 1 |
| Correra, A | 1 |
| Romeo, E | 1 |
| Palladino, MT | 1 |
| Cioppa, ND | 1 |
| Russo, MG | 1 |
| Sarubbi, B | 1 |
| Balik, M | 2 |
| Waldauf, P | 2 |
| Maly, M | 2 |
| Matousek, V | 1 |
| Brozek, T | 1 |
| Rulisek, J | 1 |
| Porizka, M | 1 |
| Sachl, R | 1 |
| Otahal, M | 1 |
| Brestovansky, P | 1 |
| Svobodova, E | 1 |
| Flaksa, M | 1 |
| Stach, Z | 1 |
| Pazout, J | 1 |
| Duska, F | 1 |
| Smid, O | 1 |
| Stritesky, M | 1 |
| Bandorski, D | 1 |
| Bogossian, H | 1 |
| Ghofrani, A | 1 |
| Schmitt, J | 1 |
| Höltgen, R | 1 |
| Bjeloševič, M | 1 |
| Illíková, V | 1 |
| Tomko, J | 1 |
| Olejník, P | 1 |
| Chalupka, M | 1 |
| Hatala, R | 1 |
| Dohain, AM | 1 |
| Lotfy, W | 1 |
| Abdelmohsen, G | 1 |
| Sobhy, R | 1 |
| Abdelaziz, O | 1 |
| Elsaadany, M | 1 |
| Abdelsalam, MH | 1 |
| Ibrahim, H | 1 |
| Yamamoto, H | 1 |
| Monno, S | 1 |
| Ohta-Ogo, K | 1 |
| Ishibashi-Ueda, H | 1 |
| Hashimoto, T | 1 |
| Környei, L | 1 |
| Szabó, A | 1 |
| Róth, G | 1 |
| Ferenci, T | 1 |
| Kardos, A | 2 |
| Kolnikova, I | 1 |
| Tavazzi, G | 1 |
| Kristof, J | 1 |
| Haverkamp, W | 1 |
| Israel, C | 1 |
| Parwani, A | 1 |
| Evans, WN | 1 |
| Acherman, RJ | 1 |
| Law, IH | 1 |
| Von Bergen, NH | 1 |
| Samson, RA | 1 |
| Restrepo, H | 1 |
| Li, XM | 1 |
| Ge, HY | 1 |
| Liu, XQ | 1 |
| Shi, L | 1 |
| Guo, BJ | 1 |
| Li, MT | 1 |
| Jiang, H | 2 |
| Zhang, Y | 2 |
| Liu, HJ | 1 |
| Zheng, XC | 1 |
| Li, AJ | 1 |
| Zhang, YY | 1 |
| Hill, AC | 1 |
| Silka, MJ | 2 |
| Bar-Cohen, Y | 2 |
| Arsenault, KA | 1 |
| Yusuf, AM | 1 |
| Crystal, E | 1 |
| Healey, JS | 1 |
| Morillo, CA | 1 |
| Nair, GM | 1 |
| Whitlock, RP | 1 |
| Kosior, DA | 1 |
| Krzykwa, A | 1 |
| Postuła, M | 1 |
| Fernández González, F | 1 |
| Miranda, S | 1 |
| Santiago Casiano, M | 1 |
| Nieves, J | 1 |
| Adorno, E | 1 |
| Fernández González, R | 1 |
| Sadoh, WE | 1 |
| Obaseki, DE | 1 |
| Amuabunos, EA | 1 |
| Eregie, CO | 1 |
| Isah, IA | 1 |
| Idemudia, E | 1 |
| Vhriterhire, CO | 1 |
| Chantepie, A | 1 |
| Lefort, B | 1 |
| Méot, M | 1 |
| Jandali, JC | 1 |
| Soulé, N | 1 |
| Chantreuil, J | 1 |
| Vaillant, MC | 1 |
| Tisseron, B | 1 |
| Kang, SL | 1 |
| Howe, D | 1 |
| Coleman, M | 1 |
| Roman, K | 1 |
| Gnanapragasam, J | 1 |
| Capone, CA | 1 |
| Gebb, J | 1 |
| Dar, P | 1 |
| Shenoy, RU | 1 |
| Peng, WS | 1 |
| Chen, X | 1 |
| Ge, H | 1 |
| Li, X | 1 |
| Liu, H | 1 |
| Ergül, Y | 1 |
| Özyılmaz, İ | 1 |
| Saygı, M | 1 |
| Tola, HT | 1 |
| Akdeniz, C | 1 |
| Tuzcu, V | 1 |
| Montero-Tinnirello, J | 1 |
| Magaldi, M | 1 |
| Fontanals, J | 1 |
| Masgoret, P | 1 |
| Bravo, JC | 1 |
| Whelchel, DD | 1 |
| Tennent-Brown, BS | 1 |
| Coleman, AE | 1 |
| Rapoport, GS | 1 |
| Blas-Machado, U | 1 |
| Maisenbacher, HW | 1 |
| Credille, BC | 1 |
| Giguère, S | 1 |
| Haas, NA | 1 |
| Camphausen, CK | 1 |
| Pézard, PG | 1 |
| Boussion, F | 1 |
| Sentilhes, L | 1 |
| Lépinard, C | 1 |
| Couvreur, MH | 1 |
| Victor, J | 2 |
| Geslin, P | 1 |
| Descamps, P | 1 |
| Masi, S | 1 |
| de Cléty, SC | 1 |
| Anslot, C | 1 |
| Detaille, T | 1 |
| Lopriore, E | 1 |
| Aziz, MI | 1 |
| Nagel, HT | 1 |
| Blom, NA | 2 |
| Rozendaal, L | 1 |
| Kanhai, HH | 1 |
| Vandenbussche, FP | 2 |
| Heisel, A | 1 |
| Berg, M | 1 |
| Stopp, M | 1 |
| Ukena, D | 1 |
| Schieffer, H | 1 |
| Luciani, R | 1 |
| Falcone, C | 1 |
| Principe, F | 1 |
| Punzo, G | 1 |
| Menè, P | 1 |
| Mihálcz, A | 1 |
| Földesi, C | 1 |
| Ladunga, K | 1 |
| Szili-Török, T | 1 |
| Dilber, E | 1 |
| Mutlu, M | 1 |
| Dilber, B | 1 |
| Aslan, Y | 1 |
| Gedik, Y | 1 |
| Celiker, A | 1 |
| Chang, PM | 1 |
| Moromisato, DY | 1 |
| Mikovic, Z | 1 |
| Karadzov, N | 1 |
| Jovanovic, I | 1 |
| Milic, V | 1 |
| Tomovic, B | 1 |
| Egic, A | 1 |
| Dragovic Lukic, G | 1 |
| Gassanov, N | 1 |
| Dietlein, M | 1 |
| Caglayan, E | 1 |
| Erdmann, E | 1 |
| Er, F | 1 |
| Saul, JP | 2 |
| LaPage, MJ | 1 |
| Abid, L | 1 |
| Trabelsi, I | 1 |
| Maazoun, Y | 1 |
| Krichène, S | 1 |
| Laroussi, L | 1 |
| Hammami, R | 1 |
| Abid, D | 1 |
| Sahnoun, M | 1 |
| Mallek, S | 1 |
| Triki, F | 1 |
| Hentati, M | 1 |
| Kammoun, S | 1 |
| Lim, SL | 1 |
| Teo, SG | 1 |
| Kireyev, D | 1 |
| Poh, KK | 1 |
| Pedro, B | 1 |
| López-Alvarez, J | 1 |
| Fonfara, S | 1 |
| Stephenson, H | 1 |
| Dukes-McEwan, J | 1 |
| Jan, SL | 1 |
| Fu, YC | 1 |
| Lin, MC | 1 |
| Hwang, B | 1 |
| Goodman, IS | 1 |
| Lu, CJ | 1 |
| Rotondi, F | 1 |
| Lanzillo, T | 1 |
| Manganelli, F | 1 |
| Lanni, F | 1 |
| Alfano, F | 1 |
| Stanco, G | 1 |
| Rosato, G | 1 |
| Meinertz, T | 1 |
| Boyce, BA | 1 |
| Yee, BH | 1 |
| García Alberola, A | 1 |
| Gómez Agüera, A | 1 |
| Sánchez Muñoz, JJ | 1 |
| Martínez Sánchez, J | 1 |
| Llamas Lázaro, C | 1 |
| Valdés Chávarri, M | 1 |
| Kasanuki, H | 1 |
| Jouannic, JM | 2 |
| Delahaye, S | 2 |
| Fermont, L | 2 |
| Le Bidois, J | 2 |
| Villain, E | 4 |
| Dumez, Y | 2 |
| Dommergues, M | 2 |
| McKee, MR | 1 |
| Walker, GM | 1 |
| McLeod, K | 1 |
| Brown, KL | 1 |
| Franklin, O | 1 |
| Goldman, AP | 1 |
| Davis, C | 1 |
| Tomek, V | 1 |
| Marek, J | 1 |
| Spálová, I | 1 |
| Vlk, R | 1 |
| Janousek, J | 1 |
| Bresták, M | 1 |
| Kulovaný, E | 1 |
| Skovránek, J | 1 |
| Doherty, G | 1 |
| Bali, S | 1 |
| Casey, F | 1 |
| McMahon, CJ | 1 |
| Laird, WP | 1 |
| Fenrich, AL | 2 |
| Ioannides, MA | 1 |
| Moutiris, JA | 1 |
| Zambartas, C | 1 |
| Ng, GY | 1 |
| Hampson Evans, DC | 1 |
| Murdoch, LJ | 1 |
| Khan, MH | 1 |
| Kuralay, E | 1 |
| Cingöz, F | 1 |
| Kiliç, S | 1 |
| Bolcal, C | 1 |
| Günay, C | 1 |
| Demirkiliç, U | 1 |
| Tatar, H | 1 |
| Barbetakis, N | 1 |
| Vassiliadis, M | 1 |
| Mayr, AJ | 1 |
| Dünser, MW | 1 |
| Ritsch, N | 1 |
| Pajk, W | 1 |
| Friesenecker, B | 1 |
| Knotzer, H | 1 |
| Ulmer, H | 1 |
| Wenzel, V | 1 |
| Hasibeder, WR | 1 |
| Scaglione, J | 1 |
| Socas, AG | 1 |
| De Palma, C | 1 |
| Kreutzer, E | 1 |
| DiDomenico, RJ | 1 |
| Massad, MG | 1 |
| Pete, B | 1 |
| Hajdú, J | 2 |
| Papp, Z | 1 |
| Serdiuk, SE | 1 |
| Bakalov, SA | 1 |
| Golitsyn, SP | 1 |
| Kotkina, TI | 1 |
| Molashenko, NV | 1 |
| Platonova, NM | 1 |
| Sviridenko, NIu | 1 |
| Sedrakyan, A | 1 |
| Treasure, T | 1 |
| Browne, J | 1 |
| Krumholz, H | 1 |
| Sharpin, C | 1 |
| van der Meulen, J | 1 |
| Grant, P | 1 |
| Malvino, E | 1 |
| Bruno, MC | 1 |
| Gallo, JP | 1 |
| Medrano, JC | 1 |
| Ferrante, D | 1 |
| Stippel, DL | 1 |
| Taylan, C | 1 |
| Schröder, W | 1 |
| Beckurts, KT | 1 |
| Hölscher, AH | 1 |
| Chouhan, UM | 1 |
| Chakrabarti, S | 1 |
| Millward, LJ | 1 |
| Scott, WA | 1 |
| Brown, S | 1 |
| Marantz, P | 1 |
| Acevedo, V | 1 |
| Etheridge, SP | 2 |
| Perry, JC | 2 |
| Triedman, JK | 1 |
| Burriss, SW | 1 |
| Cargo, P | 1 |
| Graepel, J | 1 |
| Koskelo, EK | 1 |
| Wang, R | 1 |
| Pradhan, M | 1 |
| Manisha, M | 1 |
| Singh, R | 1 |
| Kapoor, A | 1 |
| Korecki, J | 1 |
| Kamiński, KA | 1 |
| Lisowska, A | 1 |
| Musiał, WJ | 3 |
| Uzan, L | 1 |
| Guignat, L | 1 |
| Meune, C | 1 |
| Mouly, S | 1 |
| Weber, S | 1 |
| Bertagna, X | 1 |
| Bertherat, J | 1 |
| Thomopoulos, P | 1 |
| Duboc, D | 1 |
| Niinikoski, H | 1 |
| Hämäläinen, AM | 1 |
| Ekblad, H | 1 |
| Soukka, H | 1 |
| Goldschlager, N | 1 |
| Epstein, AE | 1 |
| Naccarelli, GV | 1 |
| Olshansky, B | 1 |
| Singh, B | 1 |
| Collard, HR | 1 |
| Murphy, E | 1 |
| Knirsch, W | 1 |
| Kretschmar, O | 1 |
| Vogel, M | 1 |
| Uhlemann, F | 1 |
| Bauersfeld, U | 1 |
| Celestino, D | 1 |
| Medei, E | 1 |
| Moro, S | 1 |
| Elizari, MV | 1 |
| Sicouri, S | 1 |
| Nakazawa, T | 1 |
| Murata, S | 1 |
| Kondo, T | 1 |
| Nakamura, N | 1 |
| Yamane, T | 1 |
| Iwasa, S | 1 |
| Katoh, R | 1 |
| Bourron, O | 1 |
| Ciangura, C | 1 |
| Bouillot, JL | 1 |
| Massias, L | 1 |
| Poitou, C | 1 |
| Oppert, JM | 1 |
| Di Micoli, A | 1 |
| Zambruni, A | 1 |
| Bracci, E | 1 |
| Benazzi, B | 1 |
| Zappoli, P | 1 |
| Berzigotti, A | 1 |
| Zoli, M | 1 |
| Bernardi, M | 1 |
| Trevisani, F | 1 |
| Roest, AA | 1 |
| Klumper, FJ | 1 |
| Oepkes, D | 1 |
| Rijlaarsdam, ME | 1 |
| Chen, RP | 1 |
| Ignaszewski, AP | 1 |
| Robertson, MA | 1 |
| Schmitt, C | 1 |
| Montero, M | 1 |
| Melichercik, J | 1 |
| Kurbanov, RD | 1 |
| Azimova, NA | 1 |
| Kiakbaev, GK | 1 |
| Abdullaev, TA | 1 |
| Asriiants, LS | 1 |
| Zakirov, NU | 1 |
| Avezov, DK | 1 |
| Faĭzullaev, BP | 1 |
| Moro Serrano, C | 1 |
| Hernández Madrid, A | 1 |
| Lage Silveira, J | 1 |
| Vivas Alvarez, E | 1 |
| Kanjhi, M | 1 |
| Friedman, RA | 1 |
| Bokarev, IN | 1 |
| Fomina, IG | 1 |
| De Catte, L | 2 |
| De Wolf, D | 1 |
| Smitz, J | 2 |
| Bougatef, A | 2 |
| De Schepper, J | 2 |
| Foulon, W | 2 |
| Pintér, A | 1 |
| Zámolyi, K | 1 |
| Székely, A | 1 |
| Préda, I | 1 |
| Figa, FH | 1 |
| Gow, RM | 1 |
| Hamilton, RM | 1 |
| Freedom, RM | 1 |
| Amiel, C | 1 |
| Chau, C | 1 |
| Millet, V | 1 |
| Agher, JP | 1 |
| Gamerre, M | 1 |
| Gutiérrez-Larraya, F | 1 |
| Jabón, A | 1 |
| Mathru, M | 1 |
| McDaniel, LB | 1 |
| Fulgencio, JP | 1 |
| Hamza, J | 1 |
| Manz, M | 2 |
| Lüderitz, B | 1 |
| Rogers, NK | 1 |
| Bowen, DI | 1 |
| Noble, BA | 1 |
| Hii, JT | 1 |
| Gillis, AM | 2 |
| Wyse, DG | 2 |
| Duff, HJ | 2 |
| Mitchell, LB | 2 |
| O'Kane, D | 1 |
| Campbell, NP | 1 |
| Wilson, CM | 1 |
| Adgey, AA | 1 |
| Dalzell, GW | 1 |
| Williams, MJ | 1 |
| Low, CJ | 1 |
| Restieaux, NJ | 1 |
| Assadi, S | 1 |
| Edoute, Y | 1 |
| Dick, W | 1 |
| Bossaert, L | 1 |
| Chamberlain, D | 1 |
| Painvin, I | 1 |
| Dupuis, JM | 1 |
| Rohmer, V | 1 |
| Ronceray, J | 1 |
| Tadéi, A | 1 |
| Cybulski, J | 1 |
| Kułakowski, P | 1 |
| Makowska, E | 1 |
| Czepiel, A | 1 |
| Sikora-Frac, M | 1 |
| Ceremuzyński, L | 1 |
| Szabó, I | 1 |
| Német, J | 1 |
| Leipner, N | 1 |
| Schüller, H | 1 |
| Liesenfeld, H | 1 |
| Noé, G | 1 |
| Tschubel, K | 1 |
| Ammann, R | 1 |
| Braathen, LR | 1 |
| Lee, KL | 1 |
| Tai, YT | 1 |
| Basta, M | 1 |
| Klein, GJ | 1 |
| Yee, R | 1 |
| Krahn, A | 1 |
| Lee, J | 1 |
| Tagliamonte, E | 1 |
| Cice, G | 1 |
| Ducceschi, V | 1 |
| Mayer, MS | 1 |
| Iacono, A | 1 |
| Yu, WC | 1 |
| Chen, SA | 1 |
| Lee, SH | 1 |
| Tai, CT | 1 |
| Feng, AN | 1 |
| Kuo, BI | 1 |
| Ding, YA | 1 |
| Chang, MS | 1 |
| Gandy, J | 1 |
| Wonko, N | 1 |
| Kantoch, MJ | 1 |
| Donaldson, L | 1 |
| Grant, IS | 1 |
| Naysmith, MR | 1 |
| Thomas, JS | 1 |
| Binz, K | 1 |
| Burger, A | 1 |
| Vallotton, MB | 1 |
| Bowers, PN | 1 |
| Fields, J | 1 |
| Schwartz, D | 1 |
| Rosenfeld, LE | 1 |
| Nehgme, R | 1 |
| Douchet, MP | 1 |
| Barsotti, P | 1 |
| Schneeberger, M | 1 |
| Bauer, C | 1 |
| Massard, G | 1 |
| Brechenmacher, C | 1 |
| Wihlm, JM | 1 |
| Woeber, KA | 1 |
| Warner, I | 1 |
| Bonnet, D | 1 |
| Acar, P | 1 |
| Aggoun, Y | 1 |
| Sidi, D | 1 |
| Kachaner, J | 1 |
| Mangione, R | 1 |
| Guyon, F | 1 |
| Vergnaud, A | 1 |
| Jimenez, M | 1 |
| Saura, R | 1 |
| Horovitz, J | 1 |
| Ciriaco, P | 1 |
| Mazzone, P | 1 |
| Canneto, B | 1 |
| Zannini, P | 1 |
| Schmolling, J | 1 |
| Renke, K | 1 |
| Richter, O | 1 |
| Pfeiffer, K | 1 |
| Schlebusch, H | 2 |
| Höller, T | 1 |
| Trohman, RG | 1 |
| Craig, JE | 1 |
| Compton, SJ | 1 |
| Hughes, M | 1 |
| Binning, A | 1 |
| Vanbesien, J | 1 |
| Casteels, A | 1 |
| De Bock, S | 1 |
| Tahapary, GJ | 1 |
| Suttorp, MJ | 1 |
| Sloan, SB | 1 |
| Weitz, HH | 1 |
| Hebbar, AK | 1 |
| Hueston, WJ | 1 |
| Darwiche, A | 1 |
| Vanlieferinghen, P | 1 |
| Lemery, D | 1 |
| Paire, M | 1 |
| Lusson, JR | 1 |
| Minelli, R | 1 |
| Gardini, E | 1 |
| Bianconi, L | 1 |
| Salvi, M | 1 |
| Roti, E | 1 |
| Sinha, PR | 1 |
| Dube, S | 1 |
| Gupta, PR | 1 |
| Avasthey, P | 1 |
| Somani, PN | 1 |
| Bordalo, AD | 1 |
| Ferreira, D | 1 |
| Bordalo e Sá, AL | 1 |
| Tuna, JL | 1 |
| Correia, MJ | 1 |
| Pais, F | 1 |
| Santos, F | 1 |
| Freire, JP | 1 |
| Ribeiro, C | 1 |
| Palazzuoli, V | 1 |
| Mondillo, S | 1 |
| Faglia, S | 1 |
| D'Aprile, N | 1 |
| De Luca, G | 1 |
| Kristodhullu, A | 1 |
| Corba, E | 1 |
| Vietti-Ramus, G | 1 |
| Veglio, F | 2 |
| Marchisio, U | 2 |
| Burzio, P | 2 |
| Latini, R | 1 |
| Follath, F | 1 |
| Candinas, R | 1 |
| Meyer, B | 1 |
| Sagristà-Sauleda, J | 1 |
| Permanyer-Miralda, G | 1 |
| Soler-Soler, J | 1 |
| Pongiglione, G | 1 |
| Strasburger, JF | 1 |
| Deal, BJ | 1 |
| Benson, DW | 1 |
| Unger, J | 1 |
| Mavroudakis, N | 1 |
| Lipski, A | 1 |
| van Coevorden, A | 1 |
| Bajaj, BP | 1 |
| Baig, MW | 1 |
| Perrins, EJ | 1 |
| Cabezuelo Huerta, G | 1 |
| Frontera Izquierdo, P | 1 |
| Pathé, M | 1 |
| Kahn, JC | 1 |
| Vietti Ramus, G | 1 |
| Bonino, ML | 1 |
| Bigo, P | 1 |
| Leopaldi, D | 1 |
| Ricco, G | 1 |
| Kaplan, J | 1 |
| Ish-Shalom, S | 1 |
| Rogers, JG | 1 |
| Windle, JR | 1 |
| McManus, BM | 1 |
| Easley, AR | 1 |
| Politi, G | 1 |
| Romanini, B | 1 |
| Tos, M | 1 |
| Pucci, C | 1 |
| Rescalli, S | 1 |
| Ferro, C | 1 |
| Vetter, VL | 1 |
| Garcia, JM | 1 |
| Herre, J | 1 |
| Cifarelli, A | 1 |
| Garson, A | 1 |
| Belokon', NA | 1 |
| Shkol'nikova, MA | 1 |
| Belozerov, IuM | 1 |
| Makarov, LM | 1 |
| Shvarkov, SB | 1 |
| Haines, DE | 1 |
| DiMarco, JP | 1 |
| Lucet, V | 1 |
| Do Ngoc, D | 1 |
| Denjoy, I | 1 |
| Saby, MA | 1 |
| Toumieux, MC | 1 |
| Batisse, A | 1 |
| Occhetta, E | 1 |
| Magnani, A | 1 |
| Prando, MD | 1 |
| Perucca, A | 1 |
| Rossi, L | 1 |
| Rognoni, G | 1 |
| Rossi, P | 1 |
| Piwowarska, W | 1 |
| Sniezek-Maciejewska, M | 1 |
| Bischoff, KH | 1 |
| Assmann, I | 1 |
| Dittrich, P | 1 |
| Meissner, C | 1 |
| Schwela, H | 1 |
| Gembruch, U | 1 |
| Bald, R | 1 |
| Rüddel, H | 1 |
| Redel, DA | 1 |
| Nitsch, J | 1 |
| Hansmann, M | 1 |
| Holt, AW | 1 |
| Waleffe, A | 1 |
| Nzayinambaho, K | 1 |
| Rodriguez, LM | 1 |
| Dehareng, A | 1 |
| Kulbertus, HE | 1 |
| Khmel'kova, NG | 1 |
| Stepanian, IE | 1 |
| Il'ina, IN | 1 |
| Shmelev, EI | 1 |
| Tuzcu, EM | 1 |
| Gilbo, J | 1 |
| Masterson, M | 1 |
| Maloney, JD | 1 |
| Antonelli Incalzi, R | 1 |
| Gemma, A | 1 |
| Frustaci, A | 1 |
| Rossi, E | 1 |
| Carbonin, PU | 1 |
| Lukoshiavichiute, AI | 1 |
| Gedrimene, DA | 1 |
| Bayés de Luna, A | 1 |
| Oter, MC | 1 |
| Guindo, J | 1 |
| Cabrera, A | 1 |
| Viar, M | 1 |
| Molinuevo, J | 1 |
| Zubia, A | 1 |
| Sebastián, MJ | 1 |
| Pilar, J | 1 |
| Galdeano, JM | 1 |
| Cabrera, JA | 1 |
| Pastor, E | 1 |
| Sun, JP | 1 |
| Huang, W | 1 |
| Purcaro, A | 1 |
| Capestro, F | 1 |
| Ciampani, N | 1 |
| Fratadocchi, GB | 1 |
| Mazzanti, M | 1 |
| Costantini, C | 1 |
| Molini, E | 1 |
| Casciani, M | 1 |
| Podestà, M | 1 |
| Carolis, S | 1 |
| Bargellini, F | 1 |
| Anticoli Borza, S | 1 |
| Gushchin, IV | 1 |
| Gimrikh, EO | 1 |
| Volkova, TG | 1 |
| Chernov, VI | 1 |
| Mirchev, V | 1 |
| Emmertsen, K | 1 |
| Bjerregaard, P | 1 |
| Andreasen, F | 1 |
| Kowey, PR | 1 |
| Friehling, TD | 1 |
| Marinchak, RA | 1 |
| Sulpizi, AM | 1 |
| Stohler, JL | 1 |
| Mehta, AV | 1 |
| Sanchez, GR | 1 |
| Sacks, EJ | 1 |
| Casta, A | 1 |
| Dunn, JM | 1 |
| Donner, RM | 1 |
| Rosenberg, EM | 1 |
| Elbl, F | 1 |
| Solinger, RE | 1 |
| Palakurthy, P | 1 |
| Rees, AH | 1 |
| Cascio, WE | 1 |
| Woelfel, A | 1 |
| Knisley, SB | 1 |
| Buchanan, JW | 1 |
| Foster, JR | 1 |
| Gettes, LS | 1 |
| Marchlinski, FE | 1 |
| Buxton, AE | 1 |
| Kindwall, KE | 1 |
| Miller, JM | 1 |
| Rosenthal, ME | 1 |
| Gottlieb, CD | 1 |
| Bloom, RB | 1 |
| Josephson, ME | 1 |
| Kusniec, J | 1 |
| Strasberg, B | 1 |
| Sclarovsky, S | 1 |
| Klainman, E | 1 |
| Agmon, J | 1 |
| Helmy, I | 1 |
| Herre, JM | 1 |
| Gee, G | 1 |
| Sharkey, H | 1 |
| Malone, P | 1 |
| Sauve, MJ | 1 |
| Griffin, JC | 1 |
| Scheinman, MM | 1 |
| Wang, NK | 1 |
| Liang, YC | 1 |
| Popławska, W | 2 |
| Chlewicka, I | 2 |
| Wójcik, E | 2 |
| Paczkowski, D | 2 |
| Walczak, F | 2 |
| Podleśny, J | 2 |
| Belhassen, A | 1 |
| Vaksmann, G | 1 |
| Francart, C | 1 |
| Vinatier, D | 1 |
| Patey, P | 1 |
| Monnier, JC | 1 |
| Bolińska, H | 2 |
| Radzikowska-Wasiak, M | 1 |
| Polak-Słaboszewska, D | 1 |
| Yadav, BS | 1 |
| Kaul, UA | 1 |
| Natrajan, D | 1 |
| Babu, MR | 1 |
| Bahl, VK | 1 |
| Khalilullah, M | 1 |
| Ruta, J | 1 |
| Vlahot, N | 1 |
| Morvan, J | 1 |
| Bernard, AM | 1 |
| Cleophax, JP | 1 |
| Firmin, J | 1 |
| Solares, G | 1 |
| Ramos, F | 1 |
| Martin-Durán, R | 1 |
| Ares, M | 1 |
| Santos, MA | 1 |
| Simões, LC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Randomized Study of Efficacy and Safety of 1c Class Antiarrhythmic Agent (Propafenone) in Septic Shock[NCT03029169] | Phase 4 | 210 participants (Actual) | Interventional | 2017-10-23 | Completed | ||
| A Pharmaco-surgical Approach to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery[NCT05780320] | 242 participants (Anticipated) | Observational | 2022-09-19 | Active, not recruiting | |||
| Pre-Operative Stellate Ganglion to Prevent Post-Operative Atrial Fibrillation[NCT05656170] | 0 participants (Actual) | Interventional | 2023-10-01 | Withdrawn (stopped due to Unable to begin study) | |||
| Pragmatic Amiodarone Trial to Reduce Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery[NCT05543278] | Phase 4 | 242 participants (Anticipated) | Interventional | 2023-12-01 | Not yet recruiting | ||
| Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement - a Randomized Controlled Trial[NCT05076019] | 266 participants (Anticipated) | Interventional | 2022-02-01 | Recruiting | |||
| Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins - Randomized Controlled Trial[NCT05062239] | 100 participants (Anticipated) | Interventional | 2022-04-01 | Recruiting | |||
| Multicenter Study for the Prevention of Post-Operative Cardiac Arrhythmias[NCT04234906] | Phase 4 | 870 participants (Anticipated) | Interventional | 2023-01-31 | Not yet recruiting | ||
| A Randomized Controlled Trial of Prophylactic Pulmonary Vein Isolation as Adjunct to Coronary Artery Bypass Grafting[NCT00338715] | Phase 3 | 193 participants (Actual) | Interventional | 2006-07-31 | Completed | ||
| Telemedicine Enabling Patients in Self-care Behaviors[NCT04297735] | 60 participants (Actual) | Interventional | 2020-02-26 | Completed | |||
| Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias[NCT03413150] | 80 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
31 reviews available for amiodarone and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Pharmacological Cardioversion of Atrial Tachyarrhythmias Using Single High-Dose Oral Amiodarone: A Systematic Review and Meta-Analysis.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Heart Rate; Humans; Recovery of Function; | 2021 |
[Tachycardia and pulmonary arterial hypertension].
Topics: Amiodarone; Atrial Fibrillation; Electric Countershock; Humans; Pulmonary Arterial Hypertension; Tac | 2020 |
[Clinical aspects of treatment with amiodarone].
Topics: Amiodarone; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Electrocardiograph | 2017 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2013 |
[Amiodarone-induced pulmonary toxicity].
Topics: Amiodarone; Anti-Arrhythmia Agents; Bronchial Spasm; Controlled Clinical Trials as Topic; Cryptogeni | 1997 |
[Amiodarone-induced thyroid gland dysfunctions].
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Interactions; Follow-Up Studies; Half-Life; Humans; Hyperth | 2010 |
[Supraventricular tachycardia in infants].
Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Catheter Ablation; Decision Support | 2011 |
[New generation of antiarrhythmic drug].
Topics: Amiodarone; Anti-Arrhythmia Agents; Bepridil; Coronary Disease; Humans; Randomized Controlled Trials | 1994 |
Amiodarone-an "old" drug with new recommendations.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Child; Heart Conduction System; Humans; Tachy | 2003 |
Oral class III antiarrhythmics: what is new?
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phe | 2004 |
Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin II; Anti-Arrhythmia Agents; Atrial Fibrillation | 2005 |
Pharmacologic prophylaxis for postoperative atrial tachyarrhythmia in general thoracic surgery: evidence from randomized clinical trials.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial F | 2005 |
Amiodarone in treatment of fetal supraventricular tachycardia. A case report and review of literature.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Echocardiography, Dop | 2006 |
Successful treatment of atrial flutter with amiodarone in a premature neonate. Case report and literature review.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Humans; Infant, Newborn; Infant, Premature; Tach | 2007 |
Successful treatment of supraventricular tachycardia-induced cardiomyopathy with amiodarone: case report and review of literature.
Topics: Adult; Amiodarone; Cardiomyopathies; Electrocardiography; Female; Fetal Diseases; Humans; Infant, Ne | 1995 |
[Amiodarone in the nineties: to whom and what dosage?].
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Clinical Trials | 1995 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiograp | 1993 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Fle | 1993 |
[Clinical use of intravenous amiodarone for supraventricular arrhythmias].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Humans; Infusions, In | 1995 |
Current role of pharmacologic therapy for patients with paroxysmal supraventricular tachycardia.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Calcium Channel Blockers; Digoxin; El | 1997 |
[Acute hepatitis following amiodarone administration].
Topics: Acute Disease; Amiodarone; Chemical and Drug Induced Liver Injury; Electrocardiography; Humans; Male | 1997 |
[Supraventricular arrhythmia after pneumonectomy. Apropos of 100 cases and review of the literature].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Lung Neoplasms; Male; | 1998 |
Supraventricular tachycardia: implications for the intensivist.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiogra | 2000 |
Intravenous amiodarone in intensive care. Time for a reappraisal?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Critical Care; Critical Illness; Drug Inte | 2000 |
Postoperative arrhythmias and conduction disorders.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; | 2001 |
Management of common arrhythmias: Part I. Supraventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Echocardiography, Tra | 2002 |
[A case of incessant junctional tachycardia in a female patient with aneurysm of the interauricular septum].
Topics: Amiodarone; Echinococcosis, Hepatic; Echocardiography; Electrocardiography; Female; Follow-Up Studie | 1992 |
[Supraventricular paroxysmal tachycardia without congenital heart disease: clinical, therapeutic aspects and course in 65 children].
Topics: Amiodarone; Child; Child, Preschool; Digoxin; Female; Humans; Male; Propranolol; Tachycardia, Paroxy | 1991 |
[Does amiodarone have a benefit effect on mortality?].
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Eye Diseases; France; Heart Arrest; Humans | 1991 |
Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study.
Topics: Amiodarone; Bundle of His; Digoxin; Drug Therapy, Combination; Echocardiography; Humans; Infant; Mul | 1990 |
[Amiodarone treatment in supraventricular tachycardias in childhood].
Topics: Age Factors; Amiodarone; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infant, N | 1988 |
13 trials available for amiodarone and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Double-Blind Method; | 2019 |
Supraventricular tachyarrythmia prophylaxis after coronary artery surgery in chronic obstructive pulmonary disease patients (early amiodarone prophylaxis trial).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Bypass; Female; Forced Expiratory Volume; | 2004 |
Is amiodarone a safe antiarrhythmic to use in supraventricular tachyarrhythmias after lung cancer surgery?
Topics: Adult; Age Distribution; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Huma | 2004 |
Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Child; Child, Preschool; Dose-Respon | 2005 |
[Thrombocyte aggregation in patients with cardiac arrhythmias and effect of anti-arrhythmia agents].
Topics: Aconitine; Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Heart Rate; Huma | 1993 |
Clinical efficacy and safety of intravenous Amiodarone in infants and children.
Topics: Adolescent; Amiodarone; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combina | 1994 |
Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Electroph | 1998 |
Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male | 2001 |
Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study.
Topics: Amiodarone; Bundle of His; Digoxin; Drug Therapy, Combination; Echocardiography; Humans; Infant; Mul | 1990 |
Interatrial conduction block with retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmias: influence of preventive antiarrhythmic treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; | 1989 |
Amiodarone for refractory supraventricular tachycardias.
Topics: Adolescent; Adult; Aged; Amiodarone; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Ta | 1987 |
[Amiodarone (Cordaron) in the long-term treatment of recurrent supraventricular tachycardia].
Topics: Adolescent; Adult; Aged; Amiodarone; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Re | 1986 |
Amiodarone in ventricular arrhythmias.
Topics: Adult; Aged; Amiodarone; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Tachycardia, S | 1986 |
141 other studies available for amiodarone and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Flecainide; Humans; Infant; Infant, Newborn; Propranolol; Tachyc | 2023 |
Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10-year population-based study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Pregna | 2020 |
Functional recovery of cardiomyopathy induced by atrial tachycardia in children: Insight from cardiac strain imaging.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Case-Contr | 2021 |
Delayed diagnosis of dilated thyrotoxic cardiomyopathy with coexistent multifocal atrial tachycardia: a case report.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Delayed Diagnosis; Female; Grave | 2021 |
Supraventricular tachycardias in neonates and infants: factors associated with fatal or near-fatal outcome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Female; Humans; Infant; Infant, Newborn; Pregnancy; Retro | 2021 |
Propafenone for supraventricular arrhythmias in septic shock-Comparison to amiodarone and metoprolol.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Critical Care; Electric Countershock; Female; Humans; Male | 2017 |
Neonatal complex arrhythmias possibly related to a TTN mutation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Connectin; Electrocardiography; Fetal Monit | 2017 |
[An analysis of clinical characteristics and acute treatment of supraventricular tachycardia in children from a multicenter study].
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Heart Arrest; Humans | 2018 |
A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children.
Topics: Administration, Oral; Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Femal | 2019 |
[Amiodarone administered orally or intravenously - the same or different drug?].
Topics: Action Potentials; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Node; | 2013 |
An unexpected side-effect of a commonly used drug.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arthralgia; Biopsy; Drug Eruptions; Drug Substitution; Dys | 2013 |
Cardiac rhabdomyoma in a neonate with supraventricular tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-HIV Agents; Fatal Outcome; Heart Neoplasms; Humans; Infant, | 2014 |
[Failure of amiodarone in supraventricular tachycardia in an infant: drug interaction with Gaviscon(®)?].
Topics: Alginates; Aluminum Hydroxide; Amiodarone; Antacids; Anti-Arrhythmia Agents; Drug Combinations; Drug | 2014 |
Foetal supraventricular tachycardia with hydrops fetalis: a role for direct intraperitoneal amiodarone.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetus; Gestational Age; Heart Rate, Fetal; Humans | 2015 |
Favorable neurodevelopmental outcome in a hypothyroid neonate following intracordal amiodarone for cardioversion of refractory supraventricular tachycardia in a fetus.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Hydrops Fetalis; Hypothyr | 2014 |
[Amiodarone as a second-line drug in treating neonatal paroxysmal supraventricular tachycardia].
Topics: Amiodarone; Female; Humans; Infant, Newborn; Male; Tachycardia, Supraventricular | 2015 |
[Clinical course and treatment of ectopic atrial tachycardia in 144 children].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Child; Child, Preschool; Ec | 2015 |
The use of flecainide in critical neonates and infants with incessant supraventricular tachycardias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Drug Therapy, Combination; Female; Flecainide | 2015 |
Sinusal reversion of supraventricular tachyarrhythmias after propofol administration. A case series.
Topics: Adenosine; Adult; Aged; Amiodarone; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Fema | 2017 |
Treatment of supraventricular tachycardia in a horse.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Death, Sudden; Electric Countershock; Emergencies; Hors | 2017 |
Acute hemodynamic effects of intravenous amiodarone treatment in paediatric cardiac surgical patients.
Topics: Adolescent; Algorithms; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Catecholami | 2008 |
Fetal tachycardia: a role for amiodarone as first- or second-line therapy?
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Maternal-F | 2008 |
Acute amiodarone toxicity due to an administration error: could excipient be responsible?
Topics: Amiodarone; Anti-Arrhythmia Agents; Benzyl Alcohol; Excipients; Humans; Infant, Newborn; Infusions, | 2009 |
Long-term neurodevelopmental outcome after fetal arrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Block; Child, Preschool; | 2009 |
Acute renal failure due to amiodarone-induced hypothyroidism.
Topics: Acute Kidney Injury; Aged; Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Kidney Functi | 2009 |
[Effectiveness of D,L-sotalol in post-ablative atrial arrhythmias in patients with atrial fibrillation treated with radiofrequency ablation].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control Studies; Catheter | 2009 |
Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Drug Evaluation; Drug Therap | 2010 |
Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients.
Topics: Acute Disease; Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Hear | 2010 |
Developmental delay associated with normal thyroidal function and long-term amiodarone therapy during fetal and neonatal life.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child Development; Child, Preschool; Female; Fetal Diseases; Hum | 2010 |
Is it time to tell the emperor he has no clothes?: Intravenous amiodarone for supraventricular arrhythmias in children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Evidence-Based Medicine; Humans; Injections, Intravenous; | 2010 |
Electrocardiography Series. What is the cause of the regular wide QRS complex tachycardia?
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiology; Diagnosis, D | 2011 |
Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010).
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dog Diseases; Dogs; Female; Follo | 2012 |
Precordial thump in a newborn with refractory supraventricular tachycardia and cardiovascular collapse after amiodarone administration.
Topics: Amiodarone; Bradycardia; Cardiopulmonary Resuscitation; Drug Resistance; Electrocardiography; Emerge | 2012 |
Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia.
Topics: Adenosine; Amiodarone; Catheterization, Central Venous; Combined Modality Therapy; Drug Therapy, Com | 2012 |
Atypical response of class IC atrial flutter to adenosine.
Topics: Adenosine; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Electrocardiography; Female; Hu | 2011 |
[Supraventricular extrasystole after cardioversion with amiodarone].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Premature Complex | 2012 |
Incidence and severity of phlebitis in patients receiving peripherally infused amiodarone.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheterization, P | 2012 |
[Transient atrial fibrillation induced by adenosine in a patient with atrial tachycardia].
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Hum | 2002 |
Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy?
Topics: Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Flecainide; Hydrops Fetalis; | 2003 |
Extracorporeal life support as a treatment of supraventricular tachycardia in infants.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Extracorporeal Membrane Oxygenation; Female | 2003 |
[Intraumbilical therapy of fetal supraventricular tachycardia].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Infusions, Intravenous; P | 2002 |
Fetal hydrops due to supraventricular tachycardia--successful outcome in a difficult case.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Hydrops Fetalis; Pre | 2003 |
[Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Clinical Protocols; Digoxin; Echocardiography; F | 2003 |
Amiodarone-induced 2 to 1 atrioventricular block in association with prolongation of the QT interval.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Block; Heart Conduction System; Humans; Infant, Newborn; M | 2003 |
A case of pseudocyanotic coloring of skin after prolonged use of amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Pigmentation Disorders; Tachycardia, Supra | 2003 |
Cardiovascular collapse after amiodarone administration in neonatal supraventicular tachycardia.
Topics: Adenosine; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Emergency Medicine; Extracorpor | 2003 |
High-dosage continuous amiodarone therapy to treat new-onset supraventricular tachyarrhythmias in surgical intensive care patients: an observational study.
Topics: Acid-Base Equilibrium; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Bilirubin; Creat | 2004 |
Inappropriate single chamber ICD discharges due to supraventricular tachycardia with high degree atrioventricular block.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Electrocardiography; Eq | 2004 |
[Diagnosis and treatment of haemodynamically significant fetal tachycardia--in 33 cases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Digoxin; Electric Countershock; Female; Fetal Diseases; Follow-U | 2004 |
[Lipid blood spectrum in patients with amiodarone associated hypothyroidism. Effect of replacement therapy with L-thyroxine].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cholesterol; Female; Follow-Up Studies; Humans; Hypothyroi | 2005 |
Sustained supraventricular tachycardia in Ebstein's anomaly.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Ebstein Anomaly; Electric Countershock; Fema | 2005 |
[Fetal supraventricular tachyarrhythmias refractory to initial therapy].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Female; Fetal Diseases; Flecainide; Humans; Male | 2005 |
Supraventricular tachyarrhythmia as early indicator of a complicated course after esophagectomy.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Age Factors; Amiodarone; Anastomosis, Surgical; An | 2005 |
Simvastatin interaction with clarithromycin and amiodarone causing myositis.
Topics: Amiodarone; Clarithromycin; Coronary Artery Bypass; Drug Interactions; Humans; Male; Middle Aged; My | 2005 |
Supraventricular tachycardia and pulmonary hypertension at the presentation of Hodgkin's disease.
Topics: Adult; Amiodarone; Cesarean Section; Diagnosis, Differential; Echocardiography, Doppler; Electrocard | 2005 |
Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Databases, Factual; | 2006 |
Neonatal hypothyroidism after amiodarone therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Fetal Diseases; Fetal Heart; Humans; Hypothyroidism; Infant, New | 2007 |
A practical guide for clinicians who treat patients with amiodarone: 2007.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Interactions; Female; Humans; Lung Diseases; Male; Tachycar | 2007 |
Acute in vitro effects of dronedarone, an iodine-free derivative, and amiodarone, on the rabbit sinoatrial node automaticity: a comparative study.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Dronedarone; Electrophysiology; In V | 2007 |
Histopathology of the thyroid in amiodarone-induced hypothyroidism.
Topics: Aged; Amiodarone; Amyloidosis; Anti-Arrhythmia Agents; Female; Humans; Hypothyroidism; Multiple Myel | 2008 |
Amiodarone-induced hyperthyroidism during massive weight loss following gastric bypass.
Topics: Amiodarone; Anti-Arrhythmia Agents; Gastric Bypass; Humans; Hyperthyroidism; Male; Middle Aged; Obes | 2007 |
"Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Hepatic Encephalopathy; Human | 2009 |
[Treatment of foetal supraventricular tachycardia with antiarrhythmic medication administered through the umbilical vein].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Hydrops Fetalis; Pregnanc | 2008 |
Significance of supraventricular tachyarrhythmias in patients with implanted pacing cardioverter defibrillators.
Topics: Amiodarone; Atrial Fibrillation; Chemotherapy, Adjuvant; Defibrillators, Implantable; Electrocardiog | 1994 |
Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy.
Topics: Amiodarone; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Flecainide; Follow-U | 1995 |
[Role of cordarone in the treatment of paroxysmal supraventricular tachyarrhythmia in pre-excitation syndrome].
Topics: Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Humans; Pre-Excitation Syndromes; Tachycardia | 1994 |
Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia.
Topics: Adult; Amiodarone; Digoxin; Female; Fetal Diseases; Humans; Hypothyroidism; Infant, Newborn; Male; P | 1994 |
[Amiodarone-induced hyperthyroidism causing progression of arrhythmia].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Humans; Hyperthyroidism; Male; Methi | 1994 |
[Fetal supraventricular tachycardia. Management].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Digoxin; Drug Therapy, Combination; Female; Fetal Di | 1993 |
Primum non nocere. Is the therapy worse than the disease?
Topics: Amiodarone; Humans; Lung; Lung Diseases, Interstitial; Pneumonectomy; Postoperative Complications; P | 1994 |
Anaesthesia for caesarean section in a patient receiving high dose amiodarone for fetal supraventricular tachycardia.
Topics: Adult; Amiodarone; Anesthesia, Epidural; Anesthesia, Obstetrical; Cesarean Section; Drug Interaction | 1994 |
Development of atypical amiodarone keratopathy in a corneal graft.
Topics: Aged; Amiodarone; Cornea; Corneal Diseases; Corneal Transplantation; Humans; Male; Postoperative Com | 1993 |
Risks of developing supraventricular and ventricular tachyarrhythmias after implantation of a cardioverter-defibrillator, and timing the activation of arrhythmia termination therapies.
Topics: Age Factors; Aged; Amiodarone; Arrhythmias, Cardiac; Defibrillators, Implantable; Female; Humans; In | 1993 |
Dangers of European resuscitation guidelines.
Topics: Amiodarone; Anti-Arrhythmia Agents; Europe; Humans; Practice Guidelines as Topic; Resuscitation; Tac | 1996 |
Tachycardia and cardiomyopathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomegaly; Child; Chronic Disease; Electrocardiography; Femal | 1996 |
European guidelines on resuscitation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Europe; Humans; Hypotension; Practice Guidelines as Topic; Resus | 1996 |
[Value of thyroidectomy in amiodarone-induced hyperthyroidism. Apropos of 3 cases].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Humans; Hyperthyroidism | 1996 |
Intravenous amiodarone is safe and seems to be effective in termination of paroxysmal supraventricular tachyarrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Female; Humans; Injections, Intrave | 1996 |
[Successful treatment of fetal supraventricular tachycardia with a combination of digoxin and amiodarone].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Female; Fetal Death; | 1996 |
[Early pulmonary changes caused by amiodarone].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Dose-Response Relationship, Drug; Drug A | 1996 |
[Amiodarone pigmentation].
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Eruptions; Female; Humans; Lipofuscin; Long-Term Care; Midd | 1996 |
Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety.
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; | 1997 |
Risks of intravenous amiodarone in neonates.
Topics: Age Factors; Amiodarone; Female; Humans; Hypothyroidism; Infant, Newborn; Injections, Intravenous; T | 1998 |
Acute amiodarone-induced lung toxicity.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Databases, Factu | 1998 |
[Amiodarone and thyroid function: clinical implications].
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hyperthyroidism; Male; Myocardial Infarction; Ta | 1998 |
Amiodarone induced pulmonary fibrosis in infancy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography, Ambulatory; Fo | 1998 |
Potentiation of warfarin sodium by amiodarone-induced thyrotoxicosis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Drug Synergism; Humans; International Norm | 1999 |
[Recommendations for the treatment of recurrent supraventricular tachycardia in infants].
Topics: Amiodarone; Anti-Arrhythmia Agents; Digoxin; Electric Countershock; Electrocardiography; Humans; Inf | 1998 |
Successful treatment of refractory supraventricular tachycardia by repeat intravascular injection of amiodarone in a fetus with hydrops.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Female; Fetal Diseases; Heart Rate, Fetal; Human | 1999 |
Supraventricular arrhythmia following lung resection for non-small cell lung cancer and its treatment with amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Carcinoma, Non-Small-Cell Lung; | 2000 |
Digoxin, flecainide, and amiodarone transfer across the placenta and the effects of an elevated umbilical venous pressure on the transfer rate.
Topics: Amiodarone; Anti-Arrhythmia Agents; Area Under Curve; Digoxin; Female; Fetal Diseases; Flecainide; H | 2000 |
Transient fetal hypothyroidism due to direct fetal administration of amiodarone for drug resistant fetal tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Female; Fetal Diseases; Humans; Hypothyroidism; Infant, N | 2001 |
Oral amiodarone and atrial fibrillation.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibril | 2001 |
[Amiodarone and fetal supraventricular tachycardia. Apropos of a case with neonatal hypothyroidism].
Topics: Amiodarone; Female; Heart Rate, Fetal; Humans; Hypothyroidism; Infant, Newborn; Maternal-Fetal Excha | 1992 |
Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone.
Topics: Amiodarone; Antibodies; Humans; Hypothyroidism; Male; Methimazole; Methylprednisolone; Middle Aged; | 1992 |
Adverse effects of oral amiodarone therapy.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Dose-Response Relationship, Drug; Female; Humans; Mal | 1992 |
[Arrhythmias from swallowing].
Topics: Amiodarone; Deglutition; Electrocardiography; Electrocardiography, Ambulatory; Esophagus; Exercise T | 1992 |
Efficacy and safety of short intravenous amiodarone in supraventricular tachyarrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Dose-Response Re | 1992 |
[Drug therapy in supraventricular arrhythmia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Digoxin; Flecainide; Humans; Quinidine; Tachycardia, Supraventri | 1992 |
Electrical cardioversion after amiodarone administration.
Topics: Administration, Oral; Amiodarone; Blood Pressure; Electric Countershock; Electricity; Electrocardiog | 1992 |
Use of amiodarone for short-term and adjuvant therapy in young patients.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Adult; Amiodarone; Arrhythmias, Cardi | 1991 |
Treatment of supraventricular tachyarrhythmias associated with hyperthyroidism by radioiodine, amiodarone and propylthiouracil.
Topics: Adult; Aged; Amiodarone; Combined Modality Therapy; Female; Humans; Hyperthyroidism; Iodine; Iodine | 1991 |
Amiodarone-induced torsades de pointes: the possible facilitatory role of digoxin.
Topics: Administration, Oral; Aged; Amiodarone; Digoxin; Drug Interactions; Electrocardiography; Female; Hum | 1991 |
[The acute treatment of supraventricular tachycardia with endovenous amiodarone].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Atrial Flutter; Dose-Response Relat | 1991 |
Goiter and hypothyroidism during re-treatment with amiodarone in a patient who previously experienced amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Female; Goiter; Humans; Hypothyroidism; Middle Aged; Tachycardia, Supraventricular; Thyr | 1991 |
Aspergillus myocarditis presenting as myocardial infarction with complete heart block.
Topics: Aged; Amiodarone; Aspergillosis; Aspergillus flavus; Heart; Heart Block; Humans; Lung Diseases; Male | 1990 |
[Postoperative hyperkinetic arrhythmias treated with amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Drug Evaluation; Electrocardiography; Humans; | 1990 |
[Chronic nonparoxysmal supraventricular tachycardia in children and adolescents].
Topics: Adolescent; Age Factors; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Chronic Diseas | 1990 |
Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up.
Topics: Adenosine; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cause of Death; Electric Stimulation; El | 1990 |
[Esophageal pacing in children. 38 consecutive cases].
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Child; Child, Preschool; E | 1990 |
[Arrhythmia in patients with a DDD bicameral pacemaker].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Electroc | 1986 |
Clinical value of cordarone as an antiarrhythmic agent.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, P | 1987 |
[Deglutition-induced supraventricular tachycardias].
Topics: Amiodarone; Atrial Flutter; Bundle of His; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; | 1989 |
Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis.
Topics: Adult; Amiodarone; Digoxin; Female; Fetal Diseases; Humans; Hydrops Fetalis; Injections, Intravenous | 1989 |
Hemodynamic responses to amiodarone in critically ill patients receiving catecholamine infusions.
Topics: Aged; Aged, 80 and over; Amiodarone; Cardiac Output; Catecholamines; Digoxin; Drug Synergism; Heart | 1989 |
Mechanisms of termination of supraventricular tachycardias by intravenous class III antiarrhythmic agents. A comparison of amiodarone and sotalol.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Child; Female; Heart Conduction System; Human | 1989 |
[Alveolitis in long-term intake of small doses of amiodarone].
Topics: Amiodarone; Humans; Male; Middle Aged; Pneumonia; Pulmonary Alveoli; Tachycardia, Supraventricular; | 1989 |
Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effects.
Topics: Aged; Amiodarone; Electrophysiology; Female; Humans; Male; Middle Aged; Tachycardia, Supraventricula | 1989 |
The usefulness of amiodarone in management of refractory supraventricular tachyarrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Chronic Disease; Female; Humans; Ma | 1989 |
Low atrial tachycardia as primary cause of the heart failure complicating congestive cardiomyopathy.
Topics: Amiodarone; Cardiomyopathy, Dilated; Electrocardiography; Hemodynamics; Humans; Male; Middle Aged; T | 1989 |
[Effectiveness and electrophysiologic action of amiodarone in controlling attacks of supraventricular paroxysmal tachycardia].
Topics: Action Potentials; Adolescent; Adult; Aged; Amiodarone; Atrioventricular Node; Electrocardiography; | 1989 |
Amiodarone in the treatment and control of tachyarrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Female; Humans; Male; Middle Aged; Tachycardia; Tachycar | 1986 |
[Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
Topics: Administration, Oral; Adult; Aged; Amiodarone; Drug Therapy, Combination; Electrocardiography; Femal | 1987 |
[Wolff-Parkinson-White syndrome and anesthesia].
Topics: Adult; Amiodarone; Anesthesia, General; Female; Flecainide; Humans; Propranolol; Tachycardia, Paroxy | 1987 |
[Combined effects of cordarone and ritmilen on the contractile function of the myocardium after intravenous and oral administration of loading doses].
Topics: Administration, Oral; Adult; Aged; Amiodarone; Depression, Chemical; Disopyramide; Drug Synergism; D | 1988 |
[Prevention of supraventricular tachyarrhythmia and tachycardia with kordaron].
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Evaluation; Ele | 1988 |
Safety and efficacy of amiodarone. The low-dose perspective.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; E | 1988 |
Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up.
Topics: Administration, Oral; Amiodarone; Child; Child, Preschool; Electrocardiography; Electrophysiology; F | 1988 |
Neonatal refractory supraventricular tachycardia: successful treatment with amiodarone.
Topics: Amiodarone; Electrocardiography; Electrophysiology; Female; Heart Conduction System; Humans; Infant, | 1988 |
Use dependence of amiodarone during the sinus tachycardia of exercise in coronary artery disease.
Topics: Administration, Oral; Amiodarone; Coronary Disease; Dose-Response Relationship, Drug; Electrocardiog | 1988 |
Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias.
Topics: Adult; Aged; Amiodarone; Cardiac Pacing, Artificial; Drug Combinations; Electrocardiography; Female; | 1988 |
The effect of intravenous amiodarone on heart rate in patients with acute myocardial infarction or ischemia and sinus tachycardia.
Topics: Aged; Aged, 80 and over; Amiodarone; Coronary Disease; Female; Heart Rate; Humans; Infusions, Intrav | 1988 |
Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Bradycardia; Cardiac Pacing, Artificial; Electrocardiography; Emer | 1988 |
[Chaotic atrial arrhythmia in children. Report of 14 cases].
Topics: Amiodarone; Child; Child, Preschool; Electrocardiography; Female; Humans; Infant; Male; Prognosis; T | 1987 |
[Remote results of the pharmacological treatment of patients with a high risk of sudden heart arrest in ventricular disorders of cardiac rhythm].
Topics: Adult; Aged; Amiodarone; Death, Sudden; Female; Heart Arrest; Humans; Male; Mexiletine; Middle Aged; | 1987 |
[Practical aspects of studies on amiodarone and desethylamiodarone levels in the sera of chronically treated patients].
Topics: Adolescent; Adult; Aged; Amiodarone; Humans; Middle Aged; Tachycardia, Supraventricular; Time Factor | 1987 |
[Value of amiodarone in the treatment of fetal supraventricular tachycardia. Apropos of a case].
Topics: Amiodarone; Female; Fetal Diseases; Heart Rate, Fetal; Humans; Pregnancy; Tachycardia, Supraventricu | 1987 |
[Complications after oral and intravenous administration of amiodarone (cordaron)].
Topics: Administration, Oral; Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Hyp | 1986 |
[Fetal supraventricular tachycardia. Prenatal treatment with a digoxin-amiodarone combination].
Topics: Amiodarone; Digoxin; Drug Therapy, Combination; Female; Fetal Diseases; Humans; Pregnancy; Tachycard | 1987 |
Is amiodarone an alternative to beta-blockers to treat supraventricular tachycardias in pheochromocytoma?
Topics: Adrenal Gland Neoplasms; Amiodarone; Humans; Pheochromocytoma; Tachycardia, Supraventricular | 1986 |
Paroxysmal supraventricular tachycardia in supero-inferior ventricles with intact ventricular septum.
Topics: Amiodarone; Electrocardiography; Female; Heart; Humans; Infant; Radiography; Tachycardia, Paroxysmal | 1987 |